Copyright
©The Author(s) 2016.
World J Stem Cells. Oct 26, 2016; 8(10): 332-341
Published online Oct 26, 2016. doi: 10.4252/wjsc.v8.i10.332
Published online Oct 26, 2016. doi: 10.4252/wjsc.v8.i10.332
Ref. | Study design | EPCs phenotype | CPAP effect on EPCs number |
Jelic et al[61] | Adults, both genders, flow cytometry | CD34+CD133+VEGFR2+ | Normalized after 4 wk of CPAP |
Jelic et al[62] | Adults, both genders, flow cytometry | CD34+CD133+VEGFR2+ | Normalized after 4 wk of CPAP |
Murri et al[63] | Adults, both genders, flow cytometry | CD45-CD34+CD133+VEGFR2+ | Values returned to control values after 1 mo of CPAP |
Simpson et al[67] | Adults, men, flow cytometry | CD34+KDR+ CD34+KDR+CD45- | Unchanged |
Kizawa et al[68] | Adults, men, flow cytometry | CD133+CD34+CD202b+CD45- | Values decreased after 12 wk of CPAP treatment |
Chou et al[70] | Adults, both genders, flow cytometry | CD34+ | Mobilization ratio in patients with OSAS tended to decline |
- Citation: Micheu MM, Rosca AM, Deleanu OC. Stem/progenitor cells and obstructive sleep apnea syndrome - new insights for clinical applications. World J Stem Cells 2016; 8(10): 332-341
- URL: https://www.wjgnet.com/1948-0210/full/v8/i10/332.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v8.i10.332